Glaucoma News

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from Glaukos.

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.

OCT angiography alone demonstrated superior sensitivity in detecting glaucomatous changes in the optic disc and macula compared with OCT and OCT angiography combined, according to a study published in Clinical Ophthalmology.

Stand-alone canaloplasty and trabeculotomy with the Omni surgical system showed positive real-world outcomes in reducing IOP and medication use, according to a study published in American Journal of Ophthalmology.

The Paul Glaucoma Implant, a novel glaucoma drainage device, safely and effectively managed uveitic glaucoma in children and adults, according to an analysis of midterm results published in Eye.

Resveratrol supplementation with selective laser trabeculoplasty may be an effective treatment option for glaucoma by reducing IOP and offering neuroprotective benefits, according to a paper published in Open Journal of Ophthalmology.

Extended preoperative use of topical glaucoma medications with preservatives may negatively affect long-term trabeculectomy outcomes, according to a study published in Scientific Reports.

NEW YORK — In this presentation from OSN New York, Thomas W. Samuelson, MD, of Minnesota Eye Consultants, uses surgical footage to demonstrate implantation of the Xen gel stent for the treatment of glaucoma.

NEW YORK — In this presentation from OSN New York, Manjool M. Shah, MD, discusses why stand-alone canal-based MIGS is an alternative to topical medications for glaucoma treatment.

January is National Glaucoma Awareness Month, according to Prevent Blindness, and the organization is providing free resources to educate the public on the importance of early detection and care.